However, the extent to which the effects of pharmaceutical technologic aspects of pediatric oral drugs (eg, taste, route and frequency of administration, user instructions) on patient-related outcomes (eg, efficacy, tolerability, preference, adherence) can be based on clinical evidence from the available literature is unknown.
A schematic representation of the methodology for the development, initial feasibility check and future evaluation of the TTAQ and the Patient Preference Adherence Questionnaire (PPQ) is illustrated in Fig. 1.
Symptoms, functioning, general health perception, well-being, Health-Related Quality of Life (HRQoL), patient satisfaction, preferences, adherence to treatment and other elements of healthcare and its results have been defined in this context [2 4, 6 8].
Treatment preferences, adherence and outcomes are assessed with reliable and valid measures.
Data will be collected on participant preferences, adherence to treatment, health care use and time off work.
In addition, data will be collected on participant preferences, adherence to treatment, health care use and time off work.
Patient preference and adherence: comparative US studies between two bisphosphonates, weekly risedronate and monthly ibandronate.
Andrews, SM, Sperber, NR, Gierisch, JM, Danus, S, Macy, SL, Bosworth, HB, Edelman, D, and Crowley, MJ. "Patient perceptions of a comprehensive telemedicine intervention to address persistent poorly controlled diabetes". Patient preference and adherence 11 (January 2017): 469-478.
Preference and adherence.
In practice, clinicians should consider additional factors when choosing treatment, such as patient preference and adherence.
Our study evaluated the expectation, experience, preference, and adherence of patients by asking matched questions.
